Brevibloc Injection
Product Images NDC 10019-075

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Brevibloc (NDC 10019-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Two-port Intravia Bag (Image 01)

An illustration diagram of an intravenous medication bag with labeled ports. The diagram shows the medication port designated for withdrawing initial bolus only and the delivery port for administration. This is consistent with packaging for Brevibloc (Esmolol Hydrochloride) injection, used intravenously.*

FDA Label Image

Brevibloc Structural Formula (Image 02)

Chemical structure of Esmolol Hydrochloride, the active ingredient in Brevibloc injection. The structure shows the arrangement of atoms and bonds representing the molecular formula of Esmolol Hydrochloride.*

FDA Label Image

Representative Container Label 10019-075-87 (Image 03)

Brevibloc Double Strength Premixed Injection, Esmolol Hydrochloride 20 mg/mL (2,000 mg/100 mL) in sodium chloride, injection vial label. The 100 mL vial is for single intravenous use, manufactured by Baxter Healthcare Company. The label includes dosage and storage instructions, warnings against additives, and cautions for use.*

FDA Label Image

Representative Carton Label 10019-075-87 (Image 04)

Label for Brevibloc Double Strength Premixed Injection containing Esmolol Hydrochloride in Sodium Chloride at 20 mg/mL concentration. The product is provided in 10 x 100 mL single-use INTRAVIA containers and labeled by Baxter Healthcare Company. Storage instructions specify 25°C with permissible excursions, protection from freezing, and avoidance of excessive heat. The label includes placeholders for barcode, expiration date, and lot number.*

FDA Label Image

Brevibloc Representative Container Label Ndc 10019-055-61 (Image 05)

Brevibloc Premixed Injection label for Esmolol Hydrochloride in Sodium Chloride, 10 mg/mL strength, 250 mL vial. The label indicates a total of 2,500 mg of Esmolol Hydrochloride per 250 mL, iso-osmotic with no preservative, for single intravenous use only. It includes storage instructions, cautions, and manufacturer details for Baxter Healthcare Corporation, Deerfield, IL. The label also displays the NDC 10019-055-61.*

FDA Label Image

Brevibloc Representative Carton Label 1 Of 2 Ndc 10019-055-61 (Image 06)

Packaging label for Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 10 mg/mL (2,500 mg/250 mL), intravenous injection. The label specifies storage instructions, barcode placement areas, and manufacturer as Baxter Healthcare Corporation, Deerfield, IL, USA. The label includes NDC 10019-055-61 and indicates single use containers of 250 mL each.*

FDA Label Image

Representative Brevibloc Injection Container Label (Image 07)

Label for Brevibloc Injection (Esmolol Hydrochloride) 10 mg/mL intravenous injection, 10 mL vial. The label indicates a 100 mg/10 mL concentration, ready-to-use vial, for intravenous use only. It states the product contains no preservatives and instructs to discard the unused portion. Manufactured by Baxter Healthcare Company.*

FDA Label Image

Brevibloc Representative Carton Label Ndc 10019-115-01 (Image 08)

Brevibloc Injection 100 mg/10 mL (10 mg/mL) vial carton labels for intravenous use. The packaging is for 25 x 10 mL ready-to-use single-dose vials of Esmolol Hydrochloride injection, iso-osmotic and preservative-free. Labeler is Baxter Healthcare Corporation, Deerfield, IL.*

FDA Label Image

Brevibloc Representative Carton Label Ndc 10019-115-01 (Image 09)

Brevibloc Injection (Esmolol Hydrochloride) 100 mg/10 mL (10 mg/mL) in 25 x 10 mL ready-to-use single-dose vials for intravenous use. The label states Rx only and iso-osmotic solution with no preservatives. Manufactured by Baxter Healthcare Company, the box includes storage instructions and preparation details.*

FDA Label Image

Brevibloc Representative Carton Label Ndc 10019-115-01 (Image 10)

Brevibloc Injection (Esmolol Hydrochloride) 100 mg/10 mL (10 mg/mL) intravenous injection label showing NDC 10019-115-01. The label indicates storage at 25°C (77°F), lot number ABCDE12345, and expiration date December 2099. It is manufactured for Baxter Healthcare Corporation, Deerfield, IL. The package contains 4 packs, each with 25 ready-to-use 10 mL vials (total 100 vials).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.